1-3 of 3
Ozlem Goker-Alpan
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Eliglustat maintains long-term clinical stability in patients with Gaucher disease type 1 stabilized on enzyme therapy

Clinical Trials & Observations
Timothy M. Cox, Guillermo Drelichman, Renata Cravo, Manisha Balwani, Thomas Andrew Burrow, Ana Maria Martins, Elena Lukina, Barry Rosenbloom, Ozlem Goker-Alpan, Nora Watman, Amal El-Beshlawy, Priya S. Kishnani, Maria Lucia Pedroso, Sebastiaan J. M. Gaemers, Regina Tayag, M. Judith Peterschmitt
Journal: Blood
Blood (2017) 129 (17): 2375–2383.
https://doi.org/10.1182/blood-2016-12-758409
Published: 2017
Journal Articles

Report on the Safety of Velaglucerase Alfa Enzyme Replacement Therapy in Patients with Type 1 Gaucher Disease and the Transition From Clinic to Home Infusions During Treatment Protocol HGT-GCB-058

Gregory M Pastores, Barry E Rosenbloom, MD, Neal J Weinreb, Ozlem Goker-Alpan, Rebecca Mardach, Mark Lipson, Jennifer Ibrahim, Gabriel M Cohn, David Zahrieh, Pramod K Mistry
Journal: Blood
Blood (2011) 118 (21): 1101.
https://doi.org/10.1182/blood.V118.21.1101.1101
Published: 2011
Journal Articles

Risky business: Gaucher disease and multiple myeloma

Ozlem Goker-Alpan, Ellen Sidransky
Journal: Blood
Blood (2005) 105 (12): 4546–4547.
https://doi.org/10.1182/blood-2005-03-1242
Published: 2005